# Claudia Krywiak

> Claudia Krywiak is a seed investor at Ontario Centre of Innovation backing Medical Device. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Ontario Centre of Innovation](https://shizune.co/investors/profile/oci-e51e)
- Location: Toronto, Canada
- Total investments: 11
- Last investment: May 2026
- Lead investor: 36%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/claudia-krywiak/13/b2a/983

Claudia Krywiak is a seed investor at Ontario Centre of Innovation in Toronto focused on Medical Device and Health Care. Claudia Krywiak

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 4 | 36% |
| Health Care | 3 | 27% |
| Medical | 2 | 18% |
| Biotechnology | 2 | 18% |
| Manufacturing | 2 | 18% |

27 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 55% |
| Pre-Seed | 2 | 18% |
| Grant | 1 | 9% |
| Series A | 1 | 9% |
| Convertible Note | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 9 | 82% |
| United States | 2 | 18% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Synakis | Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous. | $1.9M | Seed | May 11, 2026 |  |
| myStoria | Mystoria offers a digital platform for fertility support, empowering users with tools and knowledge for reproductive health. | $365.7K | Seed | May 11, 2026 |  |
| Talin | Talin is a company that automates personalized candidate outreach and contact enrichment, streamlining the efforts of recruiters and recruitment agencies. Talin's AI-driven platform is revolutionizing staffing agency recruitment by automating key processes like lead generation and candidate outreach, enabling efficient operation scaling. | $573.7K | Pre-Seed | Oct 02, 2024 |  |
| Quthero | Accelerating the ways we treat wounds today - from passive to rapid, & healthy wound management | $1.4M | Seed | Mar 11, 2024 |  |
| Noa Therapeutics | Noa Therapeutics is a preclinical biotech firm that is leading the way in the development of multimodal treatments. To simplify the course of care for patients in need, we developed a single, non-steroidal, small molecule with tunable efficacy | $1.6M | Pre-Seed | Mar 06, 2024 |  |
| Tenomix | Tenomix mission is to develop novel technologies that target inefficiencies in the pathology workflow optimize cancer care and reduce healthcare costs | $1.6M | Seed | Mar 01, 2024 |  |
| Evercloak | Evercloak is a manufacturer of ultra-thin graphene and other 2-d nanomaterial films designed for cleantech applications. The company's platform uses a low-cost advanced manufacturing platform which builds ultra-thin nanomaterial membranes, enabling disruptive clean technologies to reduce cost, energy use and associated greenhouse gas emissionsthroughout the oil and gas, nuclear, energy, mining and agri-food sectors. | $1.5M | Seed | Feb 13, 2024 |  |
| Novel Biotechnology | Novel Biotechnology operates as a biotechnology company and develops innovative solutions for plasmid DNA production. | $2.5M | Seed | Sep 27, 2023 |  |
| MIMOSA Diagnostics | MIMOSA Diagnostics is the maker of the MIMOSA Pro, a handheld device that uses near-infrared light to accurately and non-invasively assess tissue health. It can be easily used by a patient or a caregiver, and the images produced will help inform the next steps within patient navigation and management |  | Convertible Note | Jul 17, 2023 |  |
| TROES | TROES is a Canadian company to develop smart power energy storage technologies, products, and solutions in a 170 Billion market to help middle-market project developers, power distributors, and power consumers to unlock numerous project opportunities with considerable payback which are not existed previously due to high project cost, lack ofexpertise and low development efficiency by using our patented modularized energy storage hardware and software. |  | Grant | Jun 16, 2023 |  |

10 of 11 investments shown.

## Co-investors
- [Bioindustrial Innovation Canada](https://shizune.co/investors/profile/bioindustrial-innovation-canada) — VC Fund, 2 deals together
- [Phoenix Fire](https://shizune.co/investors/profile/phoenix-fire) — VC Fund, 2 deals together
- [Angel One Network](https://shizune.co/investors/profile/angel-one-network) — VC Fund, 1 deal together
- [Archangel Network of Funds](https://shizune.co/investors/profile/archangel-4de5) — VC Fund, 1 deal together
- [Cascade Seed Fund](https://shizune.co/investors/profile/cascade-angels-fund) — VC Fund, 1 deal together
- [DMZ Ventures](https://shizune.co/investors/profile/dmz-ventures) — VC Fund, 1 deal together

## About Ontario Centre of Innovation

VC Fund · Toronto, Canada

Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario

2 contacts available at Ontario Centre of Innovation.

| Name | Title | Profile |
| --- | --- | --- |
| Claudia Krywiak | President & CEO | https://shizune.co/investors/profile/claudia-krywiak |
| Tanya Dunn | Executive Assistant to the President & CEO | https://shizune.co/investors/profile/tanya-dunn |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Claudia Krywiak invest in?

Claudia Krywiak invests primarily in Medical Device, Health Care and Medical startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Claudia Krywiak last invest?

The most recent investment recorded for Claudia Krywiak closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
